Announced Thu, 9 Apr · 18:38 IST
Non-applicability of Annual Secretarial Compliance Report for FY2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹0.67
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.0+4.5+3.0+7.5+4.5+10.4+6.0+14.9+3.0+25.4
Up moveDown movePending
AI summary
Amerise Biosciences Ltd is exempt from filing the Annual Secretarial Compliance Report for FY26 under SEBI Regulation 15(2). Its paid-up equity capital (~Rs. 6.61 Cr) and net worth (~Rs. 5.40 Cr) fall below the thresholds of Rs. 10 Cr and Rs. 25 Cr respectively. A Practicing Company Secretary has certified the exemption.
Likely market impact
Routine compliance filing. Confirms company is small-cap and exempt from certain SEBI corporate governance rules. No material impact on stock.